Mylan Acquires Two Generics
Mylan, Inc. (NYSE:MYL), one of the leading generic drug makers in the world, recently announced the acquisition of two generic dermatological products from Canadian company Valeant Pharmaceuticals (NYSE:VRX). Mylan acquired the authorized generic version of Valeant Pharma’s Efudex cream indicated for the treatment of multiple actinic or solar keratoses. Second, Mylan has acquired the abbreviated [...]
Mylan, Inc. (NYSE:MYL), one of the leading generic drug makers in the world, recently announced the acquisition of two generic dermatological products from Canadian company Valeant Pharmaceuticals (NYSE:VRX). Mylan acquired the authorized generic version of Valeant Pharma’s Efudex cream indicated for the treatment of multiple actinic or solar keratoses.
Second, Mylan has acquired the abbreviated new drug application (ANDA) for the generic version of Valeant Pharma’s topical acne treatment … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards